Guilherme Emrich

 

Founding Partner of FIR Capital. He was a founder, CEO and then Chairman of Biobrás S.A., a company that, under his administration, grew from the start-up stage to become the fourth largest insulin producer in the world. Chairman of the Board of Trustees of Fundação Biominas, the largest biotechnology cluster in Latin America. Chairman of the Board of Directors of Biomm S.A., Member of the Board of Trustees of Fundação Dom Cabral and Chairman of CSEM Brasil. Engineering graduate, he attended several post-graduation courses in the USA and Europe.